1. Home
  2. QS vs MMED Comparison

QS vs MMED Comparison

Compare QS & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuantumScape Corporation

QS

QuantumScape Corporation

HOLD

Current Price

$4.92

Market Cap

3.6B

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$16.83

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QS
MMED
Founded
2010
1983
Country
United States
United States
Employees
N/A
2800
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.3B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
QS
MMED
Price
$4.92
$16.83
Analyst Decision
Hold
Strong Buy
Analyst Count
6
10
Target Price
$9.38
$22.56
AVG Volume (30 Days)
24.2M
1.2M
Earning Date
04-22-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
19.15
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.99
Revenue Next Year
$1,827.70
$10.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.97
$10.65
52 Week High
$19.07
$17.86

Technical Indicators

Market Signals
Indicator
QS
MMED
Relative Strength Index (RSI) 28.53 63.33
Support Level N/A $14.70
Resistance Level $7.21 N/A
Average True Range (ATR) 0.39 0.90
MACD -0.12 0.04
Stochastic Oscillator 7.02 73.31

Price Performance

Historical Comparison
QS
MMED

About QS QuantumScape Corporation

QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional nodes. The company operates in one operating segment only.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: